156 related articles for article (PubMed ID: 11919579)
1. Target cell defense prevents the development of diabetes after viral infection.
Flodström M; Maday A; Balakrishna D; Cleary MM; Yoshimura A; Sarvetnick N
Nat Immunol; 2002 Apr; 3(4):373-82. PubMed ID: 11919579
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes: virus infection or autoimmune disease?
Fairweather D; Rose NR
Nat Immunol; 2002 Apr; 3(4):338-40. PubMed ID: 11919574
[No Abstract] [Full Text] [Related]
3. Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells.
Flodström M; Tsai D; Fine C; Maday A; Sarvetnick N
Diabetes; 2003 Aug; 52(8):2025-34. PubMed ID: 12882919
[TBL] [Abstract][Full Text] [Related]
4. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection.
Flodström-Tullberg M; Hultcrantz M; Stotland A; Maday A; Tsai D; Fine C; Williams B; Silverman R; Sarvetnick N
J Immunol; 2005 Feb; 174(3):1171-7. PubMed ID: 15661870
[TBL] [Abstract][Full Text] [Related]
5. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury.
Yasukawa H; Yajima T; Duplain H; Iwatate M; Kido M; Hoshijima M; Weitzman MD; Nakamura T; Woodard S; Xiong D; Yoshimura A; Chien KR; Knowlton KU
J Clin Invest; 2003 Feb; 111(4):469-78. PubMed ID: 12588885
[TBL] [Abstract][Full Text] [Related]
6. Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse.
Flodström-Tullberg M; Yadav D; Hägerkvist R; Tsai D; Secrest P; Stotland A; Sarvetnick N
Diabetes; 2003 Nov; 52(11):2696-700. PubMed ID: 14578288
[TBL] [Abstract][Full Text] [Related]
7. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration.
Horwitz MS; Fine C; Ilic A; Sarvetnick N
J Autoimmun; 2001 May; 16(3):211-7. PubMed ID: 11334485
[TBL] [Abstract][Full Text] [Related]
8. Interferons induce an antiviral state in human pancreatic islet cells.
Hultcrantz M; Hühn MH; Wolf M; Olsson A; Jacobson S; Williams BR; Korsgren O; Flodström-Tullberg M
Virology; 2007 Oct; 367(1):92-101. PubMed ID: 17559902
[TBL] [Abstract][Full Text] [Related]
9. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.
Serreze DV; Wasserfall C; Ottendorfer EW; Stalvey M; Pierce MA; Gauntt C; O'Donnell B; Flanagan JB; Campbell-Thompson M; Ellis TM; Atkinson MA
J Virol; 2005 Jan; 79(2):1045-52. PubMed ID: 15613333
[TBL] [Abstract][Full Text] [Related]
10. [Signal cross-talk between proinflammatory cytokine and IFN-alpha].
Wei R
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):182-4. PubMed ID: 15059314
[No Abstract] [Full Text] [Related]
11. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.
Barral AM; Thomas HE; Ling EM; Darwiche R; Rodrigo E; Christen U; Ejrnaes M; Wolfe T; Kay TW; von Herrath MG
J Autoimmun; 2006 Nov; 27(3):166-73. PubMed ID: 17045460
[TBL] [Abstract][Full Text] [Related]
12. The role of viruses in the etiopathogenesis of diabetes mellitus.
Strycharz M; Bartecka K; Polz-Dacewicz M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):257-60. PubMed ID: 16145992
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
14. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.
Horwitz MS; Ilic A; Fine C; Balasa B; Sarvetnick N
Clin Immunol; 2004 Feb; 110(2):134-44. PubMed ID: 15003810
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K
J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219
[TBL] [Abstract][Full Text] [Related]
16. Loss of interferon-induced Stat1 phosphorylation in activated T cells.
Van De Wiele CJ; Marino JH; Whetsell ME; Vo SS; Masengale RM; Teague TK
J Interferon Cytokine Res; 2004 Mar; 24(3):169-78. PubMed ID: 15035850
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
[TBL] [Abstract][Full Text] [Related]
18. Viral infection of engrafted human islets leads to diabetes.
Gallagher GR; Brehm MA; Finberg RW; Barton BA; Shultz LD; Greiner DL; Bortell R; Wang JP
Diabetes; 2015 Apr; 64(4):1358-69. PubMed ID: 25392246
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
[TBL] [Abstract][Full Text] [Related]
20. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
